Department of Emergency and Organ Transplantation (DETO), University Medical School "A. Moro" of Bari, Bari, Italy.
MSc Surgical Science and Practice (Oxon).
Ann Surg. 2018 Jun;267(6):1034-1046. doi: 10.1097/SLA.0000000000002523.
The aim of this study was to evaluate the safety and efficacy of elective rectal resection for rectal cancer in adults by robotic surgery compared with conventional laparoscopic surgery.
Technological advantages of robotic surgery favor precise dissection in narrow spaces. However, the evidence base driving recommendations for the use of robotic surgery in rectal cancer primarily hinges on observational data.
We searched MEDLINE, Embase, and CENTRAL for randomized controlled trials (until August 2016) comparing robotic surgery versus conventional laparoscopic surgery. Data on the following endpoints were evaluated: circumferential margin status, mesorectal grade, number of lymph nodes harvested, rate of conversion to open surgery, postoperative complications, and operative time. Data were summarized as relative risks (RR) or weighted mean differences (WMDs) with 95% confidence intervals (95% CIs). Risk of bias of studies was assessed with standard methods.
Five trials were eligible, including 334 robotic and 337 laparoscopic surgery cases. Meta-analysis showed that RS was associated with lower conversion rate (7.3%; 4 studies, 544 participants, RR 0.58; 95% CI 0.35-0.97, P = 0.04, I = 0%) and longer operating time (MD 38.43 minutes, 95% CI 31.84-45.01: P < 0.00001) compared with laparoscopic surgery. Perioperative mortality, rate of circumferential margin involvement (2 studies, 489 participants, RR 0.82, 95% CI 0.39-1.73), and lymph nodes collected (mean 17.4 Lymph Nodes; 5 trials, 674 patients, MD -0.35, 95% CI -1.83 to 1.12) were similar. The quality of the evidence was moderate for most outcomes.
Evidence of moderate quality supports that robotic surgery for rectal cancer produces similar perioperative outcomes of oncologic procedure adequacy to conventional laparoscopic surgery. Robotic surgery portraits lower rate of conversion to open surgery, while operating time is significantly longer than by laparoscopic approach.
本研究旨在评估成人直肠癌经机器人手术与传统腹腔镜手术行择期直肠切除术的安全性和疗效。
机器人手术的技术优势有利于在狭窄的空间进行精确解剖。然而,支持推荐在直肠癌中使用机器人手术的证据基础主要依赖于观察性数据。
我们检索了 MEDLINE、Embase 和 CENTRAL,以获取比较机器人手术与传统腹腔镜手术的随机对照试验(截至 2016 年 8 月)。评估了以下终点的相关数据:环周切缘状态、中直肠分级、采集的淋巴结数量、中转开腹率、术后并发症和手术时间。数据以相对风险(RR)或加权均数差(WMD)及其 95%置信区间(95%CI)表示。采用标准方法评估研究的偏倚风险。
有 5 项试验符合纳入标准,其中机器人手术 334 例,腹腔镜手术 337 例。Meta 分析显示,RS 组的中转开腹率较低(7.3%;4 项研究,544 例参与者,RR 0.58;95%CI 0.35-0.97,P = 0.04,I = 0%),手术时间较长(MD 38.43 分钟,95%CI 31.84-45.01:P < 0.00001)。与腹腔镜手术相比,围手术期死亡率、环周切缘受累率(2 项研究,489 例参与者,RR 0.82,95%CI 0.39-1.73)和采集的淋巴结数(平均 17.4 个淋巴结;5 项研究,674 例患者,MD -0.35,95%CI -1.83 至 1.12)相似。大多数结局的证据质量为中等。
证据质量为中等的研究结果表明,机器人手术治疗直肠癌在肿瘤手术充分性方面与传统腹腔镜手术相似。机器人手术中转开腹率较低,而手术时间明显长于腹腔镜手术。